Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
95.25 EUR | -0.05% | +2.47% | -3.58% |
May. 16 | CARL ZEISS MEDITEC AG : Receives a Buy rating from UBS | ZD |
May. 10 | CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Buy rating | ZD |
Sales 2024 * | 2.24B 2.43B | Sales 2025 * | 2.52B 2.75B | Capitalization | 8.52B 9.27B |
---|---|---|---|---|---|
Net income 2024 * | 254M 276M | Net income 2025 * | 314M 342M | EV / Sales 2024 * | 3.99 x |
Net Debt 2024 * | 396M 431M | Net Debt 2025 * | 488M 530M | EV / Sales 2025 * | 3.57 x |
P/E ratio 2024 * |
33.3
x | P/E ratio 2025 * |
26.8
x | Employees | 4,950 |
Yield 2024 * |
1.11% | Yield 2025 * |
1.26% | Free-Float | 40.86% |
Latest transcript on Carl Zeiss Meditec AG
1 day | +0.03% | ||
1 week | +0.79% | ||
Current month | -3.83% | ||
1 month | -2.46% | ||
3 months | -14.45% | ||
6 months | +10.02% | ||
Current year | -3.58% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 66 | 01-12-31 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
Heike Madan
BRD | Director/Board Member | 52 | 23-03-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.71% | 202 M€ | -.--% | ||
0.52% | 2 M€ | +13.56% | - | |
0.49% | 79 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 95.3 | 0.00% | 31 259 |
24-05-17 | 95.3 | -1.60% | 142,106 |
24-05-16 | 96.85 | +1.20% | 108,269 |
24-05-15 | 95.7 | -0.57% | 185,100 |
24-05-14 | 96.25 | +3.49% | 182,244 |
Delayed Quote Xetra, May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.58% | 9.27B | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- AFX Stock